Teva Sued by UCB Over Generic Copy of Epilepsy Drug

Teva Pharmaceutical Industries Ltd., the world’s largest generic-drug maker, was sued for patent infringement by a U.S. unit of UCB SA in a bid to block plans to copy the epilepsy drug Vimpat.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.